COSCIENS Biopharma Inc. Impairment Loss Recognised In Profit Or Loss
COSCIENS Biopharma Inc. (CSCIF) reported Impairment Loss Recognised In Profit Or Loss of $0 for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-01.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ImpairmentLossRecognisedInProfitOrLoss · last filed 2019-04-01
| Period end | Impairment Loss Recognised In Profit Or Loss 12 month |
|---|---|
| 2018-12-31 | $0.00 20-F · filed 2019-04-01 |
| 2017-12-31 | -$44.00K 20-F · filed 2019-04-01 |
| 2016-12-31 | $85.00K 20-F · filed 2019-04-01 |
| 2015-12-31 | $70.00K 20-F · filed 2018-03-28 |